Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MSBase- An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis

Next Previous
Trial Profile

MSBase- An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 13 Oct 2023 Results evaluating the comparative effectiveness of ocrelizumab, a high efficacy DMT, versus interferon or glatiramer acetate in pwMS over the age of 60, are presented at the 9th Triennial joint meeting of Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis.
  • 13 Oct 2023 Results by identifying patients from this study to explore relapse and disability outcomes comparing those retreated with 3rd cycle of alemtuzumab vs those receiving different high efficacy DMT (ocrelizumab,ofatumumab, natalizumab),stratifying by time from 2nd alemtuzumab cycle to the next relapse, presented at the 9th Triennial joint meeting of Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis
  • 09 Nov 2022 Results analyzing cost effectiveness by deriving data from GLIMPSE, a real-world study evaluating treatment effectiveness of these oral DMTs in RMS patients in MSBase registry, presented at the 25th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top